Genelux Corp. (GNLX)
2.00
+0.02
(+1.01%)
USD |
NASDAQ |
Oct 23, 16:00
2.09
+0.09
(+4.50%)
After-Hours: 20:00
Genelux Market Cap : 90.21M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 90.21M |
| October 22, 2026 | 89.30M |
| October 21, 2026 | 93.36M |
| October 20, 2026 | 112.76M |
| October 19, 2026 | 110.50M |
| October 16, 2026 | 109.15M |
| October 15, 2026 | 111.86M |
| October 14, 2026 | 104.64M |
| October 13, 2026 | 113.66M |
| October 12, 2026 | 114.79M |
| October 09, 2026 | 115.46M |
| October 08, 2026 | 112.76M |
| October 07, 2026 | 113.66M |
| October 06, 2026 | 114.56M |
| October 05, 2026 | 117.27M |
| October 02, 2026 | 115.46M |
| October 01, 2026 | 113.66M |
| September 30, 2026 | 114.11M |
| September 29, 2026 | 110.50M |
| September 28, 2026 | 111.41M |
| September 25, 2026 | 111.86M |
| September 24, 2026 | 109.60M |
| September 23, 2026 | 113.44M |
| September 22, 2026 | 117.72M |
| September 21, 2026 | 115.46M |
| Date | Value |
|---|---|
| September 18, 2026 | 114.11M |
| September 17, 2026 | 114.11M |
| September 16, 2026 | 105.54M |
| September 15, 2026 | 111.41M |
| September 14, 2026 | 114.56M |
| September 11, 2026 | 112.31M |
| September 10, 2026 | 111.86M |
| September 09, 2026 | 113.66M |
| September 08, 2026 | 114.56M |
| September 04, 2026 | 110.05M |
| September 03, 2026 | 113.66M |
| September 02, 2026 | 115.01M |
| September 01, 2026 | 117.27M |
| August 31, 2026 | 117.95M |
| August 28, 2026 | 119.98M |
| August 27, 2026 | 129.90M |
| August 26, 2026 | 123.13M |
| August 25, 2026 | 122.68M |
| August 24, 2026 | 122.68M |
| August 21, 2026 | 122.68M |
| August 20, 2026 | 123.58M |
| August 19, 2026 | 120.88M |
| August 18, 2026 | 117.27M |
| August 17, 2026 | 121.78M |
| August 14, 2026 | 123.58M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| PS Ratio | 10294.34 |
| PEG Ratio | -1.779 |
| Price to Book Value | 5.598 |
| Price | 2.00 |
| Earnings Yield | -43.40% |
| PEGY Ratio | -1.779 |